Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19

Affiliations

¹ Division of Hospital Medicine, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX. Electronic address: maporres@ttuhsc.edu.
² Division of Cardiovascular Diseases, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX.
³ Division of Hematology, Department of Medicine, and the Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.

Comment

Mateo Porres-Aguilar et al. Chest. 2022 Jul.

. 2022 Jul;162(1):e69-e70.

doi: 10.1016/j.chest.2022.03.038.

¹ Division of Hospital Medicine, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX. Electronic address: maporres@ttuhsc.edu.
² Division of Cardiovascular Diseases, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX.
³ Division of Hematology, Department of Medicine, and the Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.

No abstract available

Comment on

Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report.
Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, Holley AB, Iaccarino J, Jimenez D, LeGal G, Rali P, Wells P. Moores LK, et al. Chest. 2022 Jul;162(1):213-225. doi: 10.1016/j.chest.2022.02.006. Epub 2022 Feb 12. Chest. 2022. PMID: 35167861 Free PMC article.

1. Moores L.K., Tritschler T., Brosnahan S., et al. Thromboprophylaxis in patients with COVID-2019: a brief update to the CHEST guideline and expert panel report. Chest. 2022;162(1):213–225. - PMC - PubMed
1. Moores L.K., Tritschler T., Brosnahan S., et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158(3):1143–1163. - PMC - PubMed
1. Lawler P.R., Goligher E.C., Berger J.S., et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385(9):790–802. - PMC - PubMed
1. Jiménez D., García-Sanchez A., Rali P., et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182–1196. - PMC - PubMed
1. Demelo-Rodriguez P., Farfán-Sedano A.I., Pedrajas J.M., et al. RIETE-BLEEDING Investigators. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis. J Thromb Haemost. 2021;19(8):1981–1989. - PMC - PubMed